Parameters | EHCC patients (n = 12) | AHCC patients (n = 16) | p-value | HCV patients (n = 10) | Healthy control (n = 10) | p-value |
---|---|---|---|---|---|---|
Age (years) | 60 (55–63) | 57 (52–60) | 0.193a | 64 (60–69) | 60 (56–62) | 0.0509b |
Albumin (g/dl) | 3.6 (3.2–3.6) | 2.9 (2.5–3.4) | 0.0013a | 3.9 (3.3–4.7) | 3.9 (3.2–4.6) | 0.0037b |
Total bilirubin (mg/dl) | 1.15 (0.9–1.9) | 1.4 (0.8–4.3) | 0.0105a | 0.5 (0.3–0.9) | 0.4 (0.2–0.9) | < 0.0001b |
INR | 1.15 (1.1–1.2) | 1.39 (1.2–1.65) | 0.1635a | 1.05 (1–1.29) | 0.85 (0.62–1.1) | 0.0002b |
BUN (mg/dl) | 12 (10–18) | 13 (10–26) | 0.0298a | 20 (17–24) | 17 (9–20) | 0.0012b |
Creatinine (mg/dl) | 0.75 (0.63–1) | 1.05 (0.9–1.63) | 0.0173a | 0.95 (0.8–1.1) | 0.9 (0.7–1) | 0.0344b |
AST (U/L) | 40 (33–47) | 93 (59–190) | 0.2746a | 24 (19–35) | 13 (12–18) | < 0.0001b |
ALT (U/L) | 40 (31–50) | 66 (32–95) | 0.0029a | 24 (12–52) | 17 (12–21) | 0.0006b |
AFP (ng/ml) | 5.5 (3.3–136) | 250 (65–9784) | 0.0117a | 4.6 (3.1–6.1) | 3.6 (2.5–4.6) | < 0.0001b |